Loss of renal function causes premature aging of the immune system

Blood Purification

Volumn 36, Issue 3-4, 2014, Pages 173-178

  Betjes, Michiel G H ^a   Meijers, Ruud W J ^a   Litjens, Nicolle H R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Aging; End stage renal disease; Hematopoietic stem cells; Immune system; Inflammation; Oxidative stress; Thymus; Uremia

Indexed keywords

CD16 ANTIGEN; CD28 ANTIGEN; REACTIVE OXYGEN METABOLITE;

ADAPTIVE IMMUNITY; ARTICLE; BONE MARROW CELL; CARDIOVASCULAR RISK; CELL EXPANSION; CELL LINEAGE; CELL LOSS; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DNA METHYLATION; END STAGE RENAL DISEASE; EPIGENETICS; HEMATOPOIETIC STEM CELL; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; KIDNEY TRANSPLANTATION; LYMPHOID CELL; MEMORY T LYMPHOCYTE; MONOCYTE; PREMATURE AGING; PREMATURE IMMUNOLOGICAL AGING; PRIORITY JOURNAL; TELOMERE; THYMUS; UREMIA; CELL COUNT; CELL FUNCTION; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; DNA MODIFICATION; HUMAN; IMMUNE SYSTEM; KIDNEY FUNCTION; NONHUMAN; T LYMPHOCYTE SUBPOPULATION;

AGING, PREMATURE; ANIMALS; CYTOMEGALOVIRUS INFECTIONS; EPIGENESIS, GENETIC; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNE SYSTEM; KIDNEY; KIDNEY FAILURE, CHRONIC; UREMIA;

EID: 84897492552     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000356084     Document Type: Article

References (31)

1. Verkade MA, van de Wetering J, Klepper M, Vaessen LM, Weimar W, Betjes MG: Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients. Kidney Int 2004; 66: 614-621.
2. Stewart JH, Vajdic CM, van Leeuwen MT, Amin J, Webster AC, Chapman JR, McDonald SP, Grulich AE, McCredie MR: The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant 2009; 24: 3225-3231.
3. Vaziri ND: Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 2004; 24: 469-473.
4. Anders HJ, Andersen K, Stecher B: The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int 2013; 83: 1010-1016.
5. Akar H, Akar GC, Carrero JJ, Stenvinkel P, Lindholm B: Systemic consequences of poor oral health in chronic kidney disease patients. Clin J Am Soc Nephrol 2011; 6: 218-226.
6. Meier P, Golshayan D, Blanc E, Pascual M, Burnier M: Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD. J Am Soc Nephrol 2009; 20: 1368-1384.
7. Betjes MG, Langerak AW, van der Spek A, de Wit EA, Litjens NH: Premature aging of circulating T cells in patients with end-stage renal disease. Kidney Int 2011; 80: 208-217.
8. Betjes MG: Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol 2013; 9: 255-265.
9. Betjes MG, Tuk CW, Visser CE, Zemel D, Krediet RT, Arisz L, Beelen RH: Analysis of the peritoneal cellular immune system during CAPD shortly before a clinical peritonitis. Nephrol Dial Transplant 1994; 9: 684-692.
10. Betjes MG, Visser CE, Zemel D, Tuk CW, Struijk DG, Krediet RT, Arisz L, Beelen RH: Intraperitoneal interleukin-8 and neutrophil influx in the initial phase of a CAPD peritonitis. Perit Dial Int 1996; 16: 385-392.
11. Sela S, Shurtz-Swirski R, Cohen-Mazor M, Mazor R, Chezar J, Shapiro G, Hassan K, Shkolnik G, Geron R, Kristal B: Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol 2005; 16: 2431-2438.
12. Heine GH, Ulrich C, Seibert E, Seiler S, Marell J, Reichart B, Krause M, Schlitt A, Kohler H, Girndt M: CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int 2008; 73: 622-629.
13. Peraldi MN, Berrou J, Dulphy N, Seidowsky A, Haas P, Boissel N, Metivier F, Randoux C, Kossari N, Guerin A, Geffroy S, Delavaud G, Marin-Esteban V, Glotz D, Charron D, Toubert A: Oxidative stress mediates a reduced expression of the activating receptor NKG2D in NK cells from end-stage renal disease patients. J Immunol 2009; 182: 1696-1705.
14. Vacher-Coponat H, Brunet C, Lyonnet L, Bonnet E, Loundou A, Sampol J, Moal V, Dussol B, Brunet P, Berland Y, Dignat-George F, Paul P: Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients. Nephrol Dial Transplant 2008; 23: 1406-1414.
15. Lim WH, Kireta S, Thomson AW, Russ GR, Coates PT: Renal transplantation reverses functional deficiencies in circulating dendritic cell subsets in chronic renal failure patients. Transplantation 2006; 81: 160-168.
16. Hesselink DA, Betjes MG, Verkade MA, Athanassopoulos P, Baan CC, Weimar W: The effects of chronic kidney disease and renal replacement therapy on circulating dendritic cells. Nephrol Dial Transplant 2005; 20: 1868-1873.
17. Agrawal S, Gollapudi P, Elahimehr R, Pahl MV, Vaziri ND: Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production. Nephrol Dial Transplant 2010; 25: 737-746.
18. Litjens NH, van Druningen CJ, Betjes MG: Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes. Clin Immunol 2006; 118: 83-91.
19. Litjens NH, Huisman M, van den Dorpel M, Betjes MG: Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients. J Am Soc Nephrol 2008; 19: 1483-1490.
20. Pahl MV, Gollapudi S, Sepassi L, Gollapudi P, Elahimehr R, Vaziri ND: Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression. Nephrol Dial Transplant 2010; 25: 205-212.
21. McKay D, Jameson J: Kidney transplantation and the ageing immune system. Nat Rev Nephrol 2012; 8: 700-708.
22. Meijers RW, Litjens NH, de Wit EA, Langerak AW, van der Spek A, Baan CC, Weimar W, Betjes MG: Uremia causes premature ageing of the T cell compartment in end-stage renal disease patients. Immun Ageing 2012; 9: 19.
23. Merino A, Buendia P, Martin-Malo A, Aljama P, Ramirez R, Carracedo J: Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity. J Immunol 2011; 186: 1809-1815.
24. Betjes MG, Meijers RW, de Wit LE, Litjens NH: A killer on the road: circulating CD4(+) CD28null T cells as cardiovascular risk factor in ESRD patients. J Nephrol 2012; 25: 183-191.
25. Betjes MG, Huisman M, Weimar W, Litjens NH: Expansion of cytolytic CD4+CD28-T cells in end-stage renal disease. Kidney Int 2008; 74: 760-767.
26. Meijers RW, Litjens NH, de Wit EA, Langerak AW, van der Spek A, Baan CC, Weimar W, Betjes MG: Cytomegalovirus contributes partly to uremia-associated premature immunological ageing of the T-cell compartment. Clin Exp Immunol 2013, E-pub ahead of print.
27. Zawada AM, Rogacev KS, Hummel B, Grun OS, Friedrich A, Rotter B, Winter P, Geisel J, Fliser D, Heine GH: SuperTAG methylationspecific digital karyotyping reveals uremiainduced epigenetic dysregulation of atherosclerosis-related genes. Circ Cardiovasc Genet 2012; 5: 611-620.
28. Young GH, Wu VC: KLOTHO methylation is linked to uremic toxins and chronic kidney disease. Kidney Int 2012; 81: 611-612.
29. Sportes C, Hakim FT, Memon SA, Zhang H, Chua KS, Brown MR, Fleisher TA, Krumlauf MC, Babb RR, Chow CK, Fry TJ, Engels J, Buffet R, Morre M, Amato RJ, Venzon DJ, Korngold R, Pecora A, Gress RE, Mackall CL: Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med 2008; 205: 1701-1714.
30. Ruiz S, Pergola PE, Zager RA, Vaziri ND: Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int 2013; 83: 1029-1041.
31. Scherberich JE, Nockher WA: CD14++ monocytes, CD14+/CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy. Clin Chem Lab Med 1999; 37: 209-213.